Introduction {#s1}
============

Cancers normally arise from mutations in an organism's own cells, and they either regress or continue to grow until they kill the host organism. In a few cases, however, including Tasmanian devils ([@bib40]; [@bib41]), dogs ([@bib38]; [@bib43]), and bivalves ([@bib34]; [@bib33]), cancer cells naturally transfer from one animal to another as an infectious allograft, leading to lineages of transmissible cancer that spread through the populations ([@bib35]). In bivalves, disseminated neoplasia (also called hemic neoplasia) is a leukemia-like disease that has been found in more than a dozen marine species, characterized by an amplification of rounded, polyploid cells in the hemolymph of animals that infiltrate into tissues. This disease often occurs in outbreaks and has led to significant population losses in many bivalve species ([@bib2]; [@bib10]). Pollution and retroviruses had been investigated as suspected causes, but until recently the etiology of disseminated neoplasia in bivalves was unknown. In four of the bivalve species affected by disseminated neoplasia (soft-shell clams, *Mya arenaria*; cockles, *Cerastoderma edule*; golden carpet shell clams, *Polititapes aureus*; and bay mussels, *Mytilus trossulus*), recent investigation has shown that the diseases are bivalve transmissible neoplasias (BTNs), showing that transmissible cancer may, in fact, be a common phenomenon in marine invertebrates.

Disseminated neoplasia has been reported in marine mussels as early as 1969 ([@bib21]), and has been observed consistently throughout Europe in both *M. edulis* ([@bib27]; [@bib31]; [@bib42]) and *M. galloprovincialis* ([@bib12]; [@bib11]; [@bib26]), albeit at lower prevalence than has been observed in some *M. trossulus* populations, which reached \>20% in some locations in the 1980s and was associated with population losses ([@bib2]; [@bib7]). Mussels in the genus *Mytilus* form a complex of species, including *M. trossulus*, *M. edulis*, and *M. galloprovincialis*, native to the northern hemisphere, and *M. chilensis, M. platensis, and M. planulatus*, native to the southern hemisphere ([@bib53]). These species have an anti-tropical distribution, spanning the temperate waters of the world, and they can hybridize, leading to widespread introgression of allospecific alleles ([@bib23]) as well as hybrid zones in several locations ([@bib5]). Disseminated neoplasia has been reported in four of these *Mytilus* species across multiple continents ([@bib2]; [@bib10]), but so far the only lineage of disseminated neoplasia in the genus that has been directly confirmed to be a transmissible cancer is in *M. trossulus* along the Pacific coast of British Columbia (BC), Canada ([@bib34]).

A population genetics analysis of *M. edulis* from France, conducted to detect hybridization and introgression between *Mytilus* species by detecting species-specific SNPs, identified a few individuals with unexpected 'chimeric' signals. The DNA samples from these individuals included *M. trossulus* alleles in a population where that species was absent, and the ratio of the *M. edulis* and *M. trossulus* alleles were not consistent with a diploid hybrid genome. Instead, this could be better explained by a mixture of two genotypes (one *M. edulis* and one *M. trossulus* in origin) within a single individual ([@bib45]). This suggested the hypothesis that *M. edulis* in France are affected by a BTN originating from *M. trossulus*, possibly the same lineage as previously identified in Canada. More recently, analysis of a severe mass mortality event ([@bib3]) in French mussels that began in 2014 led to the observation of disseminated neoplasia in many populations of *M. edulis* and *M. galloprovincialis* ([@bib4]), although it has not yet been determined whether this neoplasia is transmissible.

*M. chilensis* mussels are found along the western coast of South America, and disseminated neoplasia has been reported in multiple populations in Chile and Argentina since 1998 ([@bib30]; [@bib15]; [@bib9]; [@bib14]). Prevalence has varied by location, ranging from undetectable in some populations to as high as 12% in the Castro region of Chile and 13% in the Beagle Channel in southern Argentina, although no notable mass mortality events have been associated with neoplasia in these populations.

We investigated disseminated neoplasia found in *M. chilensis* from Argentina and Chile, as well as *M. edulis* from France and the Netherlands, to determine if these cancers are transmissible cancers or conventional cancers and, if transmissible, whether these cancers represent new cases of the same lineage of transmissible cancer previously reported in Canada (here termed *Mytilus* BTN1) or whether they are novel cancer lineages. *Mytilus* BTN1 was able to be distinguished from normal *M. trossulus* genotypes at both a nuclear and mitochondrial locus ([@bib34]). Through analysis of multiple genetic markers in South American *M. chilensis* and European *M. edulis* individuals, we found evidence of transmissible cancer in both populations. We found that neither cancer matched the *Mytilus* BTN1 lineage, previously found in BC *M. trossulus*, but instead the cancers in both species appear to come from a single, previously unidentified transmissible cancer, here called *Mytilus* BTN2 or *Mtr*BTN2. This BTN lineage arose from an *M. trossulus* individual, and it has since crossed into two different *Mytilus* species and is now affecting animals across both the Atlantic and Pacific Oceans and in both the Northern and Southern Hemispheres.

Results {#s2}
=======

Transmissible neoplasia in *M. chilensis* {#s2-1}
-----------------------------------------

To determine whether the disseminated neoplasia in *M. chilensis* was due to a conventional cancer or a transmissible cancer lineage, we collected 60 *M. chilensis* animals from Argentina in 2012. Histological analysis was used to diagnose the animals for the presence of disseminated neoplasia, and we observed a disease prevalence of 10%. DNA was extracted from tissues of three diseased animals and three normal animals, and an intron-spanning region in the nuclear gene Elongation Factor one alpha (*EF1α*) was amplified and sequenced. A normal individual would be expected to have one or two alleles (depending on whether it was homozygous or heterozygous at that locus), and a cancer would be expected to have its own set of alleles, derived from its original host. All three normal animals had one or two alleles, as expected, but two of the diseased animals (Mch41 and Mch42) had four distinct alleles, consistent with a mixture of two host alleles and two cancer-specific alleles ([Figure 1A](#fig1){ref-type="fig"}). Notably, each diseased sample had two alleles that were unique (corresponding to host alleles), but two alleles from animal Mch41 were nearly exact matches to two alleles from Mch42 (here notated as G and H). This is consistent with the presence of a transmissible cancer containing alleles G and H. These cancer-associated alleles were not cloned from one of the three diseased animals (Mch23), but cloning of PCR products is not very sensitive. This individual either does not have this cancer lineage or has a lower level of cancer that was not detectable with this method.

![Phylogenetic analysis of *EF1α* alleles from normal and diseased mussels.\
The *EF1α* locus was amplified, and multiple alleles were cloned from different individual normal and diseased mussels of different species and locations: *M. trossulus* from BC (black), *M. chilensis* from Argentina and Chile (red), and *M. edulis* from France and the Netherlands (blue). (**A**) A list of cloned alleles is shown, with filled boxes marking cancer-associated alleles. (**B**) Phylogenetic analysis of aligned alleles shows groups of related alleles (see [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). Names of alleles on the tree specify individual ID and allele ID. Open circles mark alleles from normal individuals and host alleles from diseased individuals. Filled circles mark cancer-associated alleles on the tree (colored by host species). The tree was rooted at the midpoint, with bootstrap values below 50 removed. Model used was HKY85+G. The scale bar marks genetic distance.\
10.7554/eLife.47788.004Figure 1---source data 1.FASTA formatted text file of *EF1α* sequence alignment.](elife-47788-fig1){#fig1}

A second collection of farmed *M. chilensis* from two locations in Chile confirmed the presence of disseminated neoplasia in these populations (9.6% in Calbuco and 4.5% in Castro). *EF1α* alleles cloned from a diseased individual from this location exactly match the G and H cancer-associated sequences from Argentina.

Phylogenetic analysis of these putative cancer-associated alleles shows that they are likely of *M. trossulus* or *M. chilensis* origin ([Figure 1B](#fig1){ref-type="fig"}). However, both cancer-associated alleles are clearly distinct from normal *M. trossulus* individuals and distinct from either allele of the previously identified BC transmissible neoplasia, *Mytilus* BTN1. Additionally, phylogenetic analysis shows that the *EF1α* S allele from *Mytilus* BTN1 (previously termed the 'minor' allele) is closely related to a subset of normal *M. trossulus* alleles. Thus, the tree is incompatible with the cancer-associated G and H alleles arising from the same cancer lineage as the *Mytilus* BTN1 S allele, although analysis of additional loci is needed to confirm this finding. The BTN found in *M. chilensis* therefore likely represents a separate, independent lineage of transmissible cancer, here called *Mytilus* BTN2.

Common transmissible cancer lineage in *M. chilensis* and *M. edulis* {#s2-2}
---------------------------------------------------------------------

The first evidence that disseminated neoplasia in European *M. edulis* was a BTN was the observation of 'chimeric' signals in a SNP detection assay, in which SNPs specific for *M. trossulus* were detected in five *M. edulis* samples out of 938. Additionally, the *M. trossulus* SNPs were detected at intermediate fluorescence ratio that could not be explained by an individual that was homozygous or heterozygous at those loci (i.e. variant allele fractions were not close to 50% or 100%) ([@bib45]). We sequenced the *EF1α* alleles present in DNA from four of these 'chimeric' samples of *M. edulis* collected from locations on the Atlantic coast of Europe and found more than the normal two alleles in three of them ([Figure 1A](#fig1){ref-type="fig"}). Only one or two alleles were observed in normal *M. edulis* from the same populations. Two alleles were shared in more than one diseased sample, suggesting that they could be from a transmissible cancer. Unexpectedly, these two cancer-associated alleles found in diseased *M. edulis* did not match the previously reported *Mytilus* BTN1 lineage, found in *M. trossulus* in Canada, but instead exactly matched those found in cancer samples from *M. chilensis* in South America (*Mytilus* BTN2) ([Figure 1B](#fig1){ref-type="fig"}).

In these European *M. edulis* cancer samples, we found alleles identical to the G allele from *M. chilensis* and two nearly identical versions of the H allele, with only one SNP between them (termed H'). Both the H and H' alleles were represented by multiple clones and found in multiple individuals, so H' likely represents a true second copy of the H allele within the cancer cells. Disseminated neoplasia is polyploid, and this result is consistent with a de novo mutation which occurred in one copy of the H allele after genome duplication (and likely after divergence of the South American and European strains of this lineage).

Confirmation of cancer lineage identity with nuclear and mitochondrial loci {#s2-3}
---------------------------------------------------------------------------

To gain more information about identity of the cancer lineage, we sequenced three additional loci using primers which amplify alleles in all three *Mytilus* species tested here. Histone 4 (*H4*) is a conserved gene present in multiple copies in the nuclear genome ([@bib20]). We amplified and cloned alleles from *M. chilensis* and *M. edulis* samples, as done with *EF1α*. We observed 2--5 alleles in diseased samples and only 1--2 in normal samples ([Figure 2A](#fig2){ref-type="fig"}). Looking only at normal alleles, there is a clear grouping based on species of origin in a phylogenetic tree ([Figure 2B](#fig2){ref-type="fig"}). There are three exceptions to this clustering, from one normal *M. trossulus* (MW59) and two diseased *M. chilensis* (Mch41 and Castro26) with some distinctly *M. edulis*-like alleles. These may reflect introgression or true hybrid individuals---MW59 also has an *EF1α* allele corresponding to *M. edulis* and likely represents a hybrid with this species, which has been introduced into Canada ([@bib13]).

![Phylogenetic analysis of *H4* alleles from normal and diseased mussels.\
The *H4* locus was amplified, and multiple alleles were cloned from different individual normal and diseased mussels of different species and locations: *M. trossulus* from BC (black), *M. chilensis* from Argentina and Chile (red), and *M. edulis* from France and the Netherlands (blue). (**A**) A list of cloned alleles is shown, with filled boxes marking cancer-associated alleles. (**B**) Phylogenetic analysis of aligned alleles shows groups of related alleles (see [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}). Names of alleles on the tree specify individual ID and allele ID. Open circles mark alleles from normal individuals and host alleles from diseased individuals. Closed circles mark cancer-associated alleles (colored by host species). The tree was rooted at the midpoint, with bootstrap values below 50 removed. Model used was HKY85+I. The scale bar marks genetic distance. Three sequences (AR7-2I, BA30-2J, and Castro26-2J) are consistent with recombination between the two cancer-associated alleles and were removed from the tree for clarity. The two alleles identified in the *Mytilus* BTN1 lineage (2A and 2A') are distinguished by a unique single base deletion in 2A', which does not show up as a difference in the tree, as gaps are treated as missing data.\
10.7554/eLife.47788.006Figure 2---source data 1.FASTA formatted text file of *H4* sequence alignment.](elife-47788-fig2){#fig2}

Two sets of cancer-associated alleles were identified from both *M. chilensis* and *M. edulis*, which group together. As with *EF1α*, the alleles associated with cancer in *M. chilensis* and *M. edulis* are distinct from the sequences of *Mytilus* BTN1 found in *M. trossulus* from Canada. Overall, the *H4* locus has less variability than the *EF1α* locus. Notably, there are alleles found in normal *M. trossulus* individuals that are exact matches to alleles found in both *Mytilus* BTN1 and *Mytilus* BTN2. These data again argue that this newly identified cancer lineage has an independent *M. trossulus* origin and that it arose from a different *M. trossulus* individual than the one that gave rise to *Mytilus* BTN1. *Mytilus* BTN1 likely arose within an *M. trossulus* individual with a 2A *H4* allele and Mytilus BTN2 arose from a different *M. trossulus* individual which carried both MR-like and KNS-like alleles.

In addition to the nuclear loci, we also amplified a control region of the mitochondrial genome (mtCR) including large subunit ribosomal RNA (lrRNA), a variable domain, and conserved domain ([@bib8]). As *Mytilus* mussels have double uniparental inheritance of mitochondria (in which all individuals inherit mitochondria maternally, but a second male-specific lineage of mitochondria is also passed down to male offspring gonads), we amplified a female allele from all individuals, and both female and male alleles from about half of the individuals (10 of 21 total) ([Figure 3A](#fig3){ref-type="fig"}). The sequences of normal *M. trossulus* and *M. edulis* are similar to previously published reference sequences from those species. In addition, we amplified a *M. trossulus*-like allele from cancer samples from both *M. edulis* and *M. chilensis*. This allele (termed 'D') is mostly female-like, but it switches to male-like sequence at the 3' end ([Figure 3B](#fig3){ref-type="fig"}). This recombinant sequence closely matches a recombinant sequence previously reported in a Baltic *M. trossulus* individual ([@bib49]; [@bib52]). Interestingly, a second *M. trossulus*-like allele (C) was found in all three cancer samples of *M. chilensis*, which also represents a recombination between female and male sequences, but with a different recombination point than the first. This argues for heteroplasmy of the cancer cells in *M. chilensis*, and either loss of this heteroplasmy in the cancer lineage infecting *M. edulis* or capture of this new mitochondrial genome in the cancer lineage infecting *M. chilensis*. These unique recombinants between female and male sequences again argue that *Mytilus* BTN1 and BTN2 represent distinct lineages of cancer. Even when considering only the region without any recombination with the male sequence ([Figure 3C](#fig3){ref-type="fig"}), both of these mitochondrial alleles are distinct from those found in normal animals and from the previously identified *Mytilus* BTN1 lineage, and the phylogenetic tree suggests that *Mytilus* BTN1 and BTN2 arose from different *M. trossulus* individuals.

![Phylogenetic analysis of mitochondrial CR alleles from normal and diseased mussels.\
The CR region of mitochondrial DNA was amplified, and multiple alleles were cloned from different individual normal and diseased mussels of different species and locations: *M. trossulus* from BC (black), *M. chilensis* from Argentina and Chile (red), and *M. edulis* from France and the Netherlands (blue). (**A**) A list of cloned alleles is shown, with filled boxes marking cancer-associated alleles. (**B**) A schematic of the rearrangement found in the cancer-associated alleles is shown with black boxes representing female-derived sequence and white boxes representing male-derived sequence (gray bars represent the likely recombination region). Parentheses mark the repeat region in allele D. (**C**) Phylogenetic analysis of aligned alleles shows groups of related alleles (see [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Names specify individual ID and allele ID. Alleles from normal individuals and host alleles from diseased individuals are marked with open circles (female allele) and open squares (male allele). Closed circles mark cancer-associated alleles (colored by host species). The tree was rooted at the midpoint, with bootstrap values below 50 removed. Model used was GTR+I. The scale bar marks genetic distance. Multiple male alleles were identified in *M. chilensis* samples, and a representative with the greatest number of clones was chosen for each individual. Reference sequences include female *M. trossulus* (AY823625.1), male *M. trossulus* (HM462081.1), female *M. edulis* (DQ198231.2), male *M. edulis* (AY823623.1), and the *M. trossulus* recombinant 62cm10 (KM192133.1).\
10.7554/eLife.47788.008Figure 3---source data 1.FASTA formatted text file of mtCR sequence alignment.](elife-47788-fig3){#fig3}

We additionally sequenced a second region in the mitochondrial DNA, the cytochrome c oxidase I gene (*COI*). Standard 'universal' molluscan primers used for barcoding ([@bib22]) did not amplify the mt*COI* allele from *Mytilus* BTN2, but by using degenerate primers flanking the region, we were able to amplify and sequence mt*COI* from all samples ([Figure 4A](#fig4){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). The mt*COI* of the male-specific mitogenome was not amplified by these primers. We identified a clear separation of the mitogenomes of all three species, with the mt*COI* from both *Mytilus* BTN1 and 2 nested within the *M. trossulus* sequences, as with the three other loci tested ([Figure 4B](#fig4){ref-type="fig"}). The *Mytilus* BTN1 allele (U) again showed clear differences from the *Mytilus* BTN2 allele (B). As in the mitochondrial control region, the closest published sequence to the *Mytilus* BTN2 allele is the sequence from 62mc10, a normal *M. trossulus* from the Baltic region. This again provides evidence that the two lineages of transmissible cancer arose from distinct *M. trossulus* individuals.

![Phylogenetic analysis of mitochondrial *COI* alleles from normal and diseased mussels.\
The mt*COI* locus was amplified, and multiple alleles were cloned from different individual normal and diseased mussels of different species and locations: *M. trossulus* from BC (black), *M. chilensis* from Argentina and Chile (red), and *M. edulis* from France and the Netherlands (blue). (**A**) A list of cloned alleles is shown, with filled boxes marking cancer-associated alleles. (**B**) Phylogenetic analysis of aligned alleles shows groups of related alleles (see [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). Names of alleles on the tree specify individual ID and allele ID. Open circles mark alleles from normal individuals and host alleles from diseased individuals. Closed circles mark cancer-associated alleles (colored by host species). The tree was rooted at the midpoint, with bootstrap values below 50 removed. Model used was GTR+G. The scale bar marks genetic distance. An additional Chilean sample was used for cloning (Castro52) as Castro26 showed difference from the other samples at this locus and a second sample was needed to infer the cancer-associated allele and confirm the mitochondrial replacement. One clone obtained from Castro26 was a recombinant between a *M. trossulus*-like sequence and an *M. chilensis*-like sequence, and it was excluded from the phylogenetic tree for clarity.\
10.7554/eLife.47788.010Figure 4---source data 1.FASTA formatted text file of mt*COI* sequence alignment.](elife-47788-fig4){#fig4}

Unexpectedly, while the B allele was found in *Mytilus* BTN2 samples from both Europe and Argentina, it was not identified in the *M. chilensis* samples from Chile. In these two samples, two mt*COI* alleles were found, and they share a common allele that is likely to be the cancer-associated allele (Q). However, this allele is different from allele B, and it is *M. chilensis*-derived. These samples show evidence of the common *Mytilus* BTN2 alleles at all other nuclear and mitochondrial loci, so this suggests that there has been recombination between cancer and host mitochondria somewhere in the *M. chilensis* population, resulting in a subset of *Mytilus* BTN2 cells in Chile with new recombinant mitogenomes.

While two alleles (C and D) were identified in the *M. chilensis* mtCR region, only one allele was detected at mt*COI*. The control region alleles C and D were very similar, with the exception of a different recombination site with the male-like sequence, so it is likely that both mitogenomes have the same sequence at the more conserved *COI* locus. Additionally, in Castro26, a second recombinant sequence was identified that was composed of half *M. trossulus* sequence and half *M. chilensis* sequence. This could represent the second cancer mitogenome (i.e. mtCR D and mt*COI* Q could be on one mitogenome and mtCR C and the recombinant mt*COI* could be the other), but it was supported by a single clone, so it is unclear if it was a PCR artifact or a true second allele. Further analysis will be required to determine the full recombinant cancer mitogenomes in the *Mytilus* BTN2 cancers in this region of Chile.

Detection of trans-oceanic cancer in multiple populations of *M. chilensis* and *M. edulis* using qPCR {#s2-4}
------------------------------------------------------------------------------------------------------

The cancer-associated alleles identified at these four loci (*EF1α*, *H4*, mtCR, mt*COI*) were detected through cloning of PCR products from most of the *M. chilensis* and *M. edulis* individuals that were diagnosed as diseased, but not all (6 of 8, 5 of 8, 7 of 8, and 8 of 9, respectively). For example, the cancer-associated *EF1α* alleles were not cloned from *M. chilensis* sample Mch23. Quantitative PCR (qPCR) was used to determine whether the diseased animals in these cases, such as Mch23, had the cancer-associated alleles at a level too low to be identified through cloning or whether the transmissible cancer allele was absent from that individual. Primers specific for one of the cancer-associated *EF1α* alleles (H) were designed, and amplification was compared to amplification from 'universal' *Mytilus EF1α* primers ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Analysis of the *M. chilensis* samples showed that the cancer-associated allele was found in all three samples from Argentina that were diagnosed as diseased, including Mch23 ([Figure 5](#fig5){ref-type="fig"}), and it was undetectable in all three normal samples. In the *M. chilensis* from the Pacific Ocean, however, we found that two of the four diseased animals had high levels of the cancer-associated allele, but the other two did not. They likely have either conventional cancer or a different transmissible cancer lineage. Additional samples of all three *Mytilus* species were analyzed by this method. In *M. edulis*, qPCR showed the presence of the cancer-associated allele in all mussels diagnosed as diseased but not in normal samples. To test whether *Mytilus* BTN2 could be present in the Canadian individuals at a low level, qPCR analysis was conducted on the original samples from which *Mytilus* BTN1 was identified ([@bib34]). The allele associated with *Mytilus* BTN2 in *M. edulis* and *M. chilensis* was undetectable in both normal and diseased *M. trossulus* samples from Canada. qPCR primers specific for both cancer-associated *H4* alleles were made, and both were detected in all animals diagnosed as diseased except for the two Chilean samples that were negative for the cancer-associated *EF1α* allele ([Figure 5](#fig5){ref-type="fig"}). One allele was present at a higher level within each diseased animal than the other, but the ratio of the two alleles was not completely consistent across all individuals, suggesting that there has been recombination or copy number variation in some subgroups of the cancer lineage. The *H4* cancer-associated alleles were also identified in several normal *M. trossulus*. This confirms that *H4* alleles found in *Mytilus* BTN2 are present in some individuals in the normal *M. trossulus* population. This is expected, as each of the two transmissible cancer lineages arose in the past from a different normal *M. trossulus* individual.

![qPCR of multiple loci confirms the presence of the cancer lineage in *M. trossulus* and *M. edulis* from multiple populations.\
Allele-specific qPCR was conducted to determine the fraction of cancer-associated alleles at the four loci: allele H at *EF1α*, allele RM and KNS at *H4*, allele C and D at mtCR, and allele B at mt*COI* (see [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). Boxes show whether the cancer-specific allele is undetectable or detectible, with a heatmap showing the fraction of the total alleles at each locus that correspond to the specific allele (the quantity of amplification with an allele-specific qPCR reaction divided by the quantity amplified with 'universal' *Mytilus* primers). Each individual mussel is marked with its ID, species, and location, and each animal that was diagnosed as containing disseminated neoplasia is marked 'Cancer'.\
10.7554/eLife.47788.012Figure 5---source data 1.Tab separated text file with qPCR data (U means undetectable).](elife-47788-fig5){#fig5}

Analysis of the two cancer-associated mitochondrial control region alleles shows that the C allele (only cloned from *M. chilensis* samples) is present in *M. chilensis* cancers at a very low level (\<1% of total allele fraction). It was also undetectable in four of eight diseased *M. edulis*, again suggesting that this heteroplasmy may be lost in some of the cancer cells spreading in the *M. edulis* population ([Figure 5](#fig5){ref-type="fig"}).

Unexpectedly, when comparing the copy number of the D allele to amplification at a conserved locus about 200 bp away (shown schematically in [Figure 3B](#fig3){ref-type="fig"}), the neoplastic samples yielded values greater than 100%. Further investigation revealed a tandem repeat in the D mitochondrial genome, with multiple copies of the control region that are targeted by allele-specific primers. A tandem repeat was confirmed by generating the reverse complement of the qPCR primers specific for allele D and amplifying and sequencing the tandem repeat junction (marked in [Figure 3B](#fig3){ref-type="fig"}). While it cannot be directly used to estimate the percent of cancer cells in a sample, this locus is a highly sensitive marker of this lineage.

Analysis of the *mtCOI* locus by qPCR confirmed that the main *Mytilus* BTN2 allele was identified in all *M. edulis* cancer samples, and in the Argentinian *M. chilensis*, but not the Chilean *M. chilensis*. This suggests that the mitochondria in the Chilean samples (Castro26 and 52) has been completely replaced with one that is a recombinant of the original *Mytilus* BTN2 *M. trossulus*-derived sequence and newly acquired *M. chilensis*-derived sequence.

Analyses at all loci confirm that two samples from Chile (Castro49 and 84) are not afflicted by *Mytilus* BTN2, while it is present at high levels in the other two diseased samples from Chile and all three tested samples from Argentina and eight from Europe. These two animals without any of the *Mytilus* BTN2 markers at any of the four loci thus do not have the *Mytilus* BTN2 cancer lineage. These data confirm that *Mytilus* BTN2 is distinct from *Mytilus* BTN1, and that it can be detected with multiple methods in both *M. chilensis* and *M. edulis* affected by disseminated neoplasia. Overall, the *EF1α* qPCR assay is the most highly sensitive and specific assay within these populations, with detection of the cancer-associated allele in all samples known to be affected by *Mytilus* BTN2 and no detectible amplification in any normal samples.

Identification of *M. trossulus*-specific SNPs in *M. chilensis* and *M. edulis* samples {#s2-5}
----------------------------------------------------------------------------------------

In order to confirm the presence of *M. trossulus*-derived cancer in *M. chilensis* and *M. edulis* individuals we tested for the presence of multiple *M. trossulus*-specific nuclear SNPs in *Mytilus* BTN2-positive specimens from Europe and Argentina, as well as additional samples of healthy mussels from those populations. Following previous studies ([@bib45]), we analysed SNP markers that are diagnostic between *M. trossulus* and either *M. edulis* or *M. chilensis*. We used 13 SNPs for each species. Five were used for both species, eight were specific to *M. edulis* hosts, and eight were specific to *M. chilensis* ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). We confirm that all six *Mytilus* BTN2-positive *M. edulis* and all three positive *M. chilensis* analysed with the SNP assay have strong fluorescence corresponding to the *M. trossulus* allele at all diagnostic loci analysed and they are clear outliers in the compound multi-locus average ([Figure 6](#fig6){ref-type="fig"}). In contrast, no normal animals of either species have a signal of an *M. trossulus* allele at more than one locus. Therefore, data from multiple independent loci provide further evidence supporting the finding that the *Mytilus* BTN2 lineage is an *M. trossulus* derived cancer.

![Identification of *M. trossulus*-specific SNPs in *M. chilensis* and *M. edulis* samples.\
Cancer and normal samples of (**A**) *M. chilensis* from Argentina and (**B**) *M. edulis* from Europe were analyzed for the presence of 13 SNPs that are diagnostic for *M. trossulus* alleles. The fraction of the fluorescence attributable to the *M. trossulus* allele is shown for each SNP, and the mean multi-locus estimate is shown on the right. SNP IDs indicate shortened names of the specific nuclear SNP loci used (see [Supplementary file 3](#supp3){ref-type="supplementary-material"}). Red points indicate *M. chilensis* and blue indicate *M. edulis*. Dark filled circles represent cancer samples, dark open circles represent normal samples which were a part of the sequence and qPCR analysis ([Figures 1](#fig1){ref-type="fig"}--[4](#fig4){ref-type="fig"}), and light open circles represent samples from an extended set of normal individuals from the same populations. Cancer samples included: Mch23, Mch41, and Mch42 for *M. chilensis*, and BA30, HO8, Ch5, Ch13, LA84, and STBRI43 from *M. edulis*. Normal samples included Mch3, Mch5, and Mch7 for *M. chilensis*, and HO9, HO19, Ch10, and Ch11 for *M. edulis*, as well as 109 additional normal *M. chilensis* and 62 additional normal *M. edulis*. See [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"} for *M. chilensis* data and [Figure 6---source data 2](#fig6sdata2){ref-type="supplementary-material"} for *M. edulis* data.\
10.7554/eLife.47788.014Figure 6---source data 1.Comma separated text file with SNP data from *M. chilensis* samples.\
10.7554/eLife.47788.015Figure 6---source data 2.Comma separated text file with SNP data from *M. edulis* samples.](elife-47788-fig6){#fig6}

Discussion {#s3}
==========

Disseminated neoplasia has been previously shown to be due to a transmissible cancer lineage in four bivalve species, including *Mytilus trossulus* ([@bib34]; [@bib33]), and the current study greatly extends both our understanding of cross-species transmission of cancer (from *M. trossulus* into two other *Mytilus* species) and our understanding of the potential for geographic spread of transmissible cancers ([Figure 7](#fig7){ref-type="fig"}). This finding of a single lineage crossing into multiple species across such vast distances is unexpected. Phylogenetic evidence from four loci and SNP data from 13 diagnostic nuclear SNPs show that the lineage identified here (*Mytilus* BTN2) is distinct from *Mytilus* BTN1, and that it too arose from a *M. trossulus* individual before crossing into other *Mytilus* species, as previously proposed ([@bib45]). The gene trees of the four loci are all concordant with each other, and are all consistent with a clonal, asexual cancer lineage derived from an *M. trossulus* cancer that is independent from *Mytilus* BTN1. The only exception to this is the observation of recombination with host mitochondrial DNA in the mitogenomes of *Mytilus* BTN2 in Chile. The age of this cancer lineage is unknown, but the other transmissible cancer with world-wide spread (canine transmissible venereal tumor; CTVT) was estimated to be thousands of years old ([@bib37]; [@bib1]). Our oldest samples are 10 years old, but if the earliest reports of disseminated neoplasia in *M. edulis* were attributable to this same lineage ([@bib21]), it would be at least 50 years old.

![Map of the spread of *Mytilus* BTN1 and 2.\
The locations of all collections in the current study are shown with circles. Diseased animals were found at all collection locations. The species collected at each location is marked. The *Mytilus* BTN1 lineage (gray) was only identified in *M. trossulus* populations in BC, Canada, while the *Mytilus* BTN2 lineage (purple) was identified in both *M. edulis* and *M. chilensis* populations in both the Pacific and Atlantic Oceans. Both cancer lineages originated in an *M. trossulus* individual, although the exact locations of the origins are unknown. The direction of spread of these cancers is unknown. Winkel-Tripel map was created by Flappiefh (Wikimedia Commons) using gringer\'s perlshaper script, and Natural Earth ([naturalearthdata.com](http://naturalearthdata.com)).](elife-47788-fig7){#fig7}

The transmission of cancer cells from the Northern to the Southern Hemisphere and from Atlantic to Pacific Oceans is remarkable, and ocean currents are unlikely to provide a mechanism for travel in either direction (especially given that anti-tropical distribution prevents a stepping-stone for trans-equatorial propagation). The most likely route of transmission is human intervention, specifically the transportation of animals harboring neoplastic cells in or on shipping vessels. While it is difficult to experimentally prove that a particular disease transmission was due to accidental transport on shipping vessels, examples of anthropogenic introduction of invasive species via shipping transport and aquaculture are common throughout the globe ([@bib36]). The accidental anthropogenic introduction of *Mytilus* species includes *M. galloprovincialis* introduced in northern Chile ([@bib17]) and Argentina ([@bib53]), *M. edulis* introduced in BC ([@bib13]) and the Kerguelen Islands ([@bib24]), and *M. trossulus* into Scotland ([@bib18]). Since *Mytilus* species are known to adhere to ships and spread accidentally across the world, and transmissible cancer can have an incubation period of weeks to months, any diseased animal which adheres to a ship could lead to the spread of a transmissible cancer to new and potentially susceptible populations. If transmissible cancers are able to readily travel along shipping lines and infect closely related species, then this and other lineages of transmissible cancer have the potential for world-wide reach.

When identifying identical or nearly identical sequences in samples from different locations, care must be taken to prevent a small amount of contamination from leading to a false positive. In this case, the initial sequencing and amplification of the *EF1α* loci from *M. edulis* and *M. chilensis* samples were conducted by different people at different sites before any plasmids containing the sequence from one site had been transferred to the other. The *EF1α* qPCR assay was independently replicated on European *M. edulis* infected individuals in two labs, in USA and France. Also, the finding of slight differences between the two subgroups of this cancer lineage argue against a single source of contamination. Additionally, qPCR verification confirms that a significant fraction of the DNA of each sample contains the cancer-associated allele, and that it is not found in DNA samples from normal animals, which have been treated in the same way. Therefore, the data could not be due to contamination with a small amount of DNA and represents genuine identification of a nearly identical cancer from mussels of different continents and species.

Invertebrates do not possess a vertebrate-like adaptive immune system or a major histocompatibility complex, which vertebrates utilize for discriminating self from nonself. However, in most previously identified cases of BTN, the neoplasia has only been identified in the species of origin ([@bib34]; [@bib33]), and attempts to experimentally transfer neoplastic cells from *M. trossulus* or the soft-shell clam *Mya arenaria* into several bivalve species have only been successful when the transfer is between members of the same species ([@bib29]; [@bib32]). The species in the *Mytilus* complex are able to hybridize, so the barrier to cross-species transmission may be relatively low. However, it has been reported that the disseminated neoplasia found on the Pacific coast of North America (which was identified as originating from *M. trossulus*) was found in *M. trossulus* at a much higher prevalence than *M. edulis* in the same region ([@bib39]), which suggested that the *M. trossulus* cancer preferentially infected *M. trossulus* hosts. It is currently unknown whether *Mytilus* BTN2 would be able to infect its original host species or if the original host has evolved resistance, as was suggested with the cancer derived from the pullet shell clam *Venerupis corrugata* ([@bib34]). *M. chilensis* is closely related to *M. edulis*, and it has even been suggested that it could be considered a subspecies, *M. edulis platensis* ([@bib6]), although this is controversial ([@bib53]), so once the cancer was able to cross into either *M. chilensis* or *M. edulis*, the second jump into the other species may have presented a lower barrier. Based on analysis of transmissible cancers in devils and dogs it has been hypothesized that transmissible cancers primarily occur in inbred populations, but the finding of this cancer spreading into highly outbred individuals from multiple different species within the same genus shows that this constraint is not universal.

The evidence for mitochondrial heteroplasmy and recombination observed in this cancer lineage and its loss or gain is a very interesting observation that suggests a dynamic mitochondrial population in BTN, which may not exactly match the nuclear evolutionary path. It has been shown that mitochondria in CTVT has been replaced several times by mitochondrial capture of new normal mitochondrial genomes ([@bib44]; [@bib50]), so a dynamic mitochondrial population may be a common feature among transmissible cancers. It is also possible that one of the two cancer-associated mtCR regions could be a nuclear-to-mitochondrial transfer (numt) of a copy of the control region instead of mitochondrial heteroplasmy, as this possibility cannot be excluded by PCR of total extracted DNA. If this were the case, the sequences would still be evidence of an *M. trossulus*-derived transmissible cancer that is distinct from *Mytilus* BTN1. Mitochondrial replacement has not yet been described in any BTN, so further analysis will be required to determine the full recombinant cancer mitogenomes and to test whether there is any selective advantage of this recombinant mitogenome in *Mytilus* BTN2.

Comparison of cancer-associated sequences to those found in normal *M. trossulus* populations may allow us to identify the location of the origin of these cancer lineages. BLAST searches for the neoplasia-associated alleles most closely match *M. trossulus* from the Baltic and BC. The *Mytilus* BTN2 recombinant mitochondrial sequences closely match the recombinant sequence first identified in the Baltic (62mc10), but this haplotype is actually rare in the Baltic, with similar recombinant haplotypes more commonly found on the coast of Norway ([@bib49]). This suggests that this cancer lineage originated in Northern Europe, but it may not necessarily be from the Baltic. However, there are populations of *M. trossulus* in many locations around the world, and not all have been sequenced at the loci analyzed here. Additionally, the mtCR C and D alleles may be directly related to 62mc10, or they may represent novel recombinations in the same region (there is a single base difference in the recombination region between the D allele and 62mc10 which suggests that the recombination points are not identical). Multiple recombination events in which male sequence has recombined into the female mitochondrial lineage in that region (including several cases with tandem duplications) have been identified in *M. trossulus* ([@bib8]). Additionally, while exact matches of a *Mytilus* BTN2 *H4* allele was identified in *M. trossulus* from BC, exact matches of the alleles at other loci have not been identified in any wild *M. trossulus* populations. Therefore, the exact population of origin of this cancer remains uncertain.

Overall, these data show that two lineages of cancer from two separate *M. trossulus* individuals have turned into BTN lineages, and one of these lineages (*Mytilus* BTN2) has spread world-wide throughout multiple host species. This spread also suggests that anthropogenic influence may exacerbate the spread of cancers and may allow access into new environments and new populations, where the pathogenic potential is unknown.

Materials and methods {#s4}
=====================

*M. chilensis* collection and diagnosis {#s4-1}
---------------------------------------

60 individual market-sized mussels (mean, 67.6 mm; range, 52--92 mm in the longest axis) were collected in February 2012 from a culture at Bahía Brown (54°52´S, 67°31´W), Beagle Channel, Argentina. The soft parts of the specimens were carefully removed from their shells and fixed in Davidson's solution for 24 hr. Oblique transverse sections, approximately 5 mm thick, including mantle, gills, gonad, digestive gland, nephridia, and foot were taken from each specimen. Tissue samples were embedded in paraffin, and 5 μm sections were stained with hematoxylin and eosin. Histological sections were examined using a Leica DM 2500 light microscope for the presence of neoplastic cells. Small samples of gill from each mussel were preserved in 100% ethanol for DNA extraction.

200 individuals were collected from farmed populations at two sites in Chile (Calbuco and Castro). Hemolymph was drawn from adductor muscle, centrifuged at low speed and the hemocytes were stored in RNAlater (ThermoFisher Scientific) for DNA extraction. The animals were opened and the full body with one valve were fixed for at least one week with 10% formaldehyde in PBS. Tissue samples were embedded in paraffin, sectioned and stained as above. The animals were diagnosed as diseased if infiltration of hemocytes with a high nucleus-cytoplasm ratio and granular chromatin were observed.

Healthy mussels from other populations of *M. chilensis* around Punta Arenas, Chile (n = 46) and from islands around Parque Nacional Alberto de Agostini, Chile (n = 63) were analyzed with the SNP assay.

*M. edulis* collection and diagnosis {#s4-2}
------------------------------------

We used a collection of samples (gills in 90% ethanol) accumulated by the ISEM lab for years in their study of hybridization and introgression in the *M. edulis* complex of species. *M. trossulus* is not naturally found in France and the genetic analysis of thousands of individuals did not identify any *M. trossulus* individuals even in ports or mussel farms ([@bib48]). As a consequence, a signal of amplification of trossulus alleles at several diagnostic SNPs was used as a diagnosis for mussels likely infected by a *M. trossulus* BTN ([@bib45]). Here we first used specimens identified by Riquet et al.: two mussels sampled in the Arcachon Bay (South-West of France) in 2016 (AR5 and AR7), one mussel sampled in Barfleur (Normandy, France) in 2015 (BA30), and one mussel sampled in the Wadden Sea (The Netherlands) in 2009 (HO8). To these four mussels already described, we added two additional mussels identified in a new extensive genetic survey of \>4000 individuals ([@bib48]). These two mussels were collected from Chausey Island (English Channel) in 2009 (Ch5 and Ch13). For comparison, two healthy individuals were randomly chosen from each of the collections from Chausey, Barfleur, and the Wadden Sea (Ch10, Ch11, BA12, BA24, HO9, HO19). Additional healthy mussels from the populations of Chausey (n = 9), Barfleur (n = 28) and Wadden Sea (n = 21) were analyzed with the SNP assay.

In parallel, a hemocytological analysis was undertaken to identify BTN infected mussels on approximately one hundred individuals from Brittany. Briefly, the mussels were anaesthetized by bathing them for 30 min in a solution containing 50 g/L of magnesium chloride dissolved in two-thirds of distilled water and one-third of sea water ([@bib51]). 40 μl of hemolymph were withdrawn from the adductor muscle with a sterile 1 mL syringe fitted with a 27-gauge needle. After the addition of 160 μl of artificial seawater, the hemolymph solution was 'cytospun' onto coated slides (Shandon Cytospin four and Cytoslides, Thermo Scientific; 10 min, 800 rpm), fixed, stained with May-Grünwald Giemsa, and observed under light microscopy. The whole area of the cell spot on the cytoslide was observed in all the samples in search of neoplastic cells, characterized by an enlarged diameter, elevated nucleus-cytoplasm ratio, and high basophily. Two individuals that also showed a signal of *M. trossulus* allele amplification from gill tissue DNA were chosen for the present study. One was sampled in Lannion (LA84) and the other in Saint Brieux (STBRI43) in 2017. An additional normal individual from Saint Brieux (STBRI28) was also analyzed as a control, and additional healthy individuals from Lannion (n = 4) were analyzed with the SNP assay.

DNA extraction {#s4-3}
--------------

DNA was extracted from ethanol-fixed gill and siphon samples using DNeasy Blood and Tissue Kit (Qiagen) with the following additional steps to remove PCR-inhibiting polysaccharides. After tissue lysis, 65 µl of P3 Buffer (Qiagen) was added for 5 min to precipitate out polysaccharides and spun down at 17k × g at 4°C for 5 min. The resulting supernatant was transferred to a new tube, 200 µl of Buffer AL was added, and the manufacturer's protocol resumed. DNA was extracted from hemocyte samples using the standard DNeasy Blood and Tissue Kit protocol.

PCR and cloning {#s4-4}
---------------

Primers and annealing temperatures are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. PCR amplification at the *EF1α* locus was done using PfuUltra II Fusion HS DNA Polymerase (Agilent) with a 15 s extension time. Amplification at the *H4,* mtCR, and mt*COI* loci were achieved using Q5 Hot Start High-Fidelity DNA Polymerase (NEB) with a 30 s extension time. Primers for *H4* were designed to span the full *H4* gene ([@bib20]). Primers for mtCR were adapted from Burzynski et al. and were designed to cover lrRNA, a variable domain, and a conserved domain in the mitochondrial DNA control region ([@bib8]). 'Pan-molluscan' barcoding primers ([@bib22]) did not amplify the *Mytilus* BTN2 mt*COI* allele, so degenerate primers flanking the standard mt*COI* were used. In all cases, 25--50 ng of genomic DNA was amplified for 35 cycles.

PCR products were gel extracted using spin columns (Qiagen, NEB) and either directly sequenced, or, when multiple alleles at a locus could not be resolved by direct sequencing, were cloned using the Zero Blunt TOPO PCR Cloning Kit (Invitrogen). Plasmids were transformed into TOP10 or DH5α competent *E. coli* (Invitrogen) and 6--12 clones were picked for further sequencing using M13F and M13R primers (Genewiz). The primer binding regions were excluded from sequence analysis, and all unique alleles were identified. In cases where a sequence was found in only a single clone and that clone differed by \<0.5% (two differences for *EF1α* and *H4*, three for mtCR) from another allele that was supported by more than one clone from the same individual, the sequence with higher support was used as the correct allele. Additionally, a sequence which was found in only one clone and which is consistent with a recombination event between two alleles from the same sample was discarded. For *EF1α*, every allele presented was found in at least two clones (two sequences found only in single clones were removed from analysis). Alleles were named arbitrarily, such that each allele name (A-2H) represents the same sequence at that locus.

Phylogenetic analysis {#s4-5}
---------------------

Coding sequences had minimal indels and were aligned manually. The mtCR locus was aligned with MUSCLE 3.8.31 ([@bib19]) with minor manual adjustment. Maximum likelihood phylogenetic trees were generated using PhyML 3.0 ([@bib28]), with 100 bootstrap replicates, which treats gaps in the alignment as missing data, with automatic model selection through Akaike Information Criterion. Trees were visualized using FigTree version 1.4.4. All alignments are included as source data, and all sequences available in GenBank (accession numbers: *EF1α*, MN546736-MN546756; *H4*, MN546757 - MN546792; mtCR, MN546793 - MN546830; mt*COI*, MN546831 - MN546858).

qPCR {#s4-6}
----

Cancer-associated allele-specific qPCR was performed in *M. trossulus*, *M. edulis*, and *M. chilensis* genomic DNA samples using PowerUp SYBR Green Master Mix (Applied Biosystems). For all targets, one primer set was designed to specifically amplify a cancer-associated allele for a given locus (*EF1α*: Allele H; *H4*: Allele RM and KNS; mtCR: Allele C and D: mt*COI*: Allele B). A second pair of universal control primers were designed to amplify all *Mytilus* alleles at each locus. Primers are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. Standards for all targets consisted of a single plasmid containing the relevant cancer-associated allele target, which was linearized by NotI-HF (NEB) restriction digest before qPCR. Serial dilutions (10^7^--10^1^ copies) of linearized standard plasmid in triplicate were used to generate a standard curve for each qPCR run. In all experimental cases, 10--100 ng of each genomic DNA sample was run in triplicate 10 µl reactions.

All qPCR assays were performed using the Applied Biosystems StepOnePlus Real-Time PCR System (Applied Biosystems) and associated software. Allele-specific qPCR at the *EF1α* locus was comprised of a 3-step cycling stage (95°C for 15 s, 50°C for 15 s, and 60°C for 30 s, respectively) for 40 cycles, whereas qPCR at the *H4,* mtCR, and mt*COI* loci were run using a 2-step cycling stage protocol (95°C for 15 s, 60°C for 30 s) for 40 cycles. A melting curve was generated to determine amplification specificity according to the following parameters: an initial denaturation step at 95°C for 15 s, followed by a gradual temperature increase from 60°C to 95°C (Ramp of +0.3°C). The ratio of the cancer-associated allele to all alleles present at a given locus was calculated for each sample using the average copy number amplified by cancer-associated primers in triplicate reactions divided by the average copy number amplified by the universal primers in triplicate reactions. For each sample, the limit of detection for the allele-specific qPCR was set at 10 copies/reaction, and DNA samples were discarded if the universal *Mytilus* reaction at any of the loci yielded \<5000 copies/reaction (upper limit of detection of 0.2%).

SNP array {#s4-7}
---------

The SNPs used were previously described ([@bib47]). They were identified as being diagnostic (nearly fixed for alternative alleles) in a large sequence dataset ([@bib23]) and were subsequently verified to remain diagnostic with larger sample sizes ([@bib48]). Non-hybrid individuals can nonetheless occasionally be heterozygous at one, or very rarely at two, of these diagnostic loci because incomplete lineage sorting and introgression is pervasive in the *M. edulis* complex of species ([@bib25]), but never at more than two loci. Genotyping was subcontracted to LGC-genomics and performed with the Kompetitive Allele Specific PCR (KASP) chemistry ([@bib46]). The results are a combination of two fluorescence values, one for allele 1 (x), and another for allele 2 (y), the *M. trossulus*-specific allele. Following a method used for genotyping polyploids ([@bib16]), we transformed the data to have a single measure of the relative fluorescence of the two alleles, from 0 when the fluorescence of allele one dominates, to one when the fluorescence of allele 2 (*i.e.* the *M. trossulus* allele) dominates, using the following formula: y'=y/(x+y). The fluorescence of the *M. trossulus* alleles was averaged over all 13 diagnostic loci for each species to obtain a compound multi-locus estimate (see [Supplementary file 3](#supp3){ref-type="supplementary-material"}).
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United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A single clonal lineage of transmissible cancer identified in two marine mussel species in South America and Europe\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom served as guest Reviewing Editor, and the evaluation has been overseen by Patricia Wittkopp as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The identification of an independent origin of a transmissible cancer has the potential to impact the field significantly. This can inform on the likelihood of neoplastic transformation and transmission. In this paper the authors argue that an infectious cancer in two mussel species likely originated in a third species. Bivalve neoplasia had been previously documented in this third species (*M. trossulus*), but the authors claim that the cancer from this study differs from the previously identified cancer in *M. trossulus*. The authors are making two claims: (1) BTN2 is distinct from BTN1, and (2) BTN2 has spread from the Pacific coast of South America to the Atlantic coast of Europe.

Essential Revisions:

1\) Sequencing additional loci is needed to definitively show that BTN2 in Chile/Argentina is in fact the same cancer strain found in Europe. Also, sequencing less than 1kb over 3 loci makes drawing conclusions about origin and hybridization tricky. As example, how did they determine that the EF1a \'cancer\' alleles were not copy number variants in the host? Were noncancerous tissues tested for absence of these alleles in carrier individuals? Finally, with such small sequencing, how are the authors certain they are not sequencing numts, which are common in numerous marine invertebrate species. Additional sequencing will be needed to respond to this.

2\) Gene trees and species trees are often discordant, and the authors have not sampled enough loci and enough of the coalescent history to resolve this discordance. Gene discordance across the genome is now more the rule than the exception. The single coalescent history of the asexual BTN lineage should help ameliorate some of this, but more than three markers are needed. Also, in the same vein, the authors themselves highlight, their \"tree\" is incompatible with the G and H alleles coming from BTN1S. But this is based on one locus, which is insufficient.

Issues that affect interpretation of the data: response should either include significant clarification or rewriting of sections:

1\) What is meant by \"a fraction\" of *M. trossulus*\" SNPs? How many? Might this be sequencing error?

2\) What is meant by: We sequenced...and found more than the normal two alleles in \"most\" of them...What is \"most\"? There are many such examples.

3\) The qPCR results from attempted cloning of disease alleles is confusing. Finding that two of four disease *M. chilensis* animals have high levels of the cancer associated allele while the other two did not -- are the authors suggesting yet another transmissible cancer lineage?

4\) Given the inability to consistently amplify cancer alleles in various samples, it is unclear how any conclusions regarding the contribution of the Canadian samples and *M. trossulus* can be made.

5\) It is also unclear how to interpret the fact that H4 cancer associated alleles are found in several normal *M. trossulus* animals. How many is \"some?\"

6\) Sequencing less than 1kb over 3 loci makes drawing conclusions about origin and hybridization tricky. As example, how did they determine that the EF1a \'cancer\' alleles were not copy number variants in the host? Were noncancerous tissues tested for absence of these alleles in carrier individuals? Specifically, looking only at normal alleles, there is a clear grouping based on species of origin in a phylogenetic tree There are three exceptions to this clustering, from one normal *M. trossulus* (MW59) and two diseased *M. chilensis* (Mch41 and Castro26) with some distinctly *M. edulis*-like alleles. These may reflect introgression or true hybrid individuals-MW59 also has an EF1α allele corresponding to *M. edulis* and likely represents a hybrid with this species, which has been introduced into Canada (Crego-Prieto et al., 2015).\" This sort of noise, although expected, becomes problematic when it encompasses a third of the data. Please explain in more detail your rationale for your conclusions and include a discussion of caveats.

10.7554/eLife.47788.025

Author response

> Essential Revisions:
>
> 1\) Sequencing additional loci is needed to definitively show that BTN2 in Chile/Argentina is in fact the same cancer strain found in Europe. Also, sequencing less than 1kb over 3 loci makes drawing conclusions about origin and hybridization tricky. As example, how did they determine that the EF1a \'cancer\' alleles were not copy number variants in the host? Were noncancerous tissues tested for absence of these alleles in carrier individuals? Finally, with such small sequencing, how are the authors certain they are not sequencing numts, which are common in numerous marine invertebrate species. Additional sequencing will be needed to respond to this.

We have now included additional sequence data which support these claims. We have sequence data from an additional mitochondrial locus (mt*COI*), which confirms that alleles from *M. edulis* and *M. chilensis* are identical and derived from *M. trossulus*, and that they are distinct from *Mytilus* BTN1 (Figure 4). We did find that two samples from Chile showed evidence of recombination (the only evidence of recombination detected so far across all loci tested). We also used a SNP array on cancerous mussels as well as a large sample of healthy individuals to identify the presence of SNPs that are unique to *M. trossulus* (Figure 6). This allowed us to look at many independent nuclear loci to confirm that the cancer cells are *M. trossulus* in origin, and that this signal of *M. trossulus* SNPs could not be found in any normal animals from *M. chilensis* or *M. edulis* populations.

Regarding the question of whether the additional alleles could be simply copy number variation, the reviewers are correct that the finding of multiple alleles alone is not sufficient to support the claim of a transmissible cancer -- the key finding is that there are multiple alleles and that some of those are cancer-associated alleles that are identical between independent individuals. Genome duplication within an *M. chilensis* individual, for example, would be expected to give rise to multiple alleles phylogenetically related to normal *M. chilensis* alleles. It would not be expected to give rise to a second allele which is nearly identical to that of a different species. And it would not be expected to generate exactly the same sequence in multiple individuals from two different species.

Additionally, we saw no evidence of multiple alleles in any normal samples. When conducting PCR and sequencing from total DNA it is not possible to distinguish a true mitochondrial gene from a nuclear-to-mitochondrial transfer (numt). The reviewers are correct that we cannot rule this out, and we have clarified this in the text. However, if one of the cancer associated "mtCR" alleles were to be a numt, for example, it would not change the conclusion that there is sequence derived from *M. trossulus* mitochondrial DNA that is nearly identical in cancers across multiple individuals in two species.

> 2\) Gene trees and species trees are often discordant, and the authors have not sampled enough loci and enough of the coalescent history to resolve this discordance. Gene discordance across the genome is now more the rule than the exception. The single coalescent history of the asexual BTN lineage should help ameliorate some of this, but more than three markers are needed. Also, in the same vein, the authors themselves highlight, their \"tree\" is incompatible with the G and H alleles coming from BTN1S. But this is based on one locus, which is insufficient.

Gene trees and species trees are often discordant, but as the reviewers mention, a clonal transmissible cancer is asexual, so we do not expect to see discordance between a gene tree and a cancer lineage tree except in the case of recombination. We do see some discordance in the normal sexual mussel samples, as expected (i.e. *M. chilensis* has introgressed *M. trossulus* sequence at the *EF1alpha* locus and a small number of individuals appear to be hybrids), but we see no discordance between any of the gene trees in any of the four loci, with the exception of the mitochondrial recombination at one locus in two Chilean samples. Also, at all loci, the gene trees support a clonal expansion of a nearly identical asexual lineage derived from *M. trossulus* and distinct from *Mytilus* BTN1. We had specifically highlighted the evidence that neither allele G nor H were likely to have a common cancer ancestor with allele S, as noted, but we had not specifically mentioned that each other locus provides similar evidence. For example, at *H4*, normal *M. trossulus* samples were identified with alleles that were exactly identical to the alleles found in both *Mytilus* BTN1 and 2. It is therefore unlikely that BTN1 and 2 arose from a single individual and multiple loci diverged to become more closely related to other normal sequences in the population. We have clarified this in the text. The addition of the fourth locus and the data from 13 *M. trossulus*-specific SNPs should also provide further evidence of these claims.

> Issues that affect interpretation of the data: response should either include significant clarification or rewriting of sections:
>
> 1\) What is meant by \"a fraction\" of M. trossulus\" SNPs? How many? Might this be sequencing error?

This was a brief explanation of previously published data in which a SNP array was used to assay diversity in a population of *M. edulis* individuals, and it was worded unclearly. The authors of that study noted that at some loci, there was a fluorescence signal corresponding to the *M. trossulus* allele, which should not be present in the population. More unexpected, however, was the fact that the alleles were not the expected fraction of the total alleles. A single SNP would be expected to be present at 0% (allele 1 homozygous), 50% (heterozygous with both alleles 1 and 2), or 100% (allele 2 homozygous) of the DNA at a single locus in a sample, but in these samples the fraction of the *M. trossulus* alleles were between these numbers (e.g. 30%). This suggested that the DNA sample tested could be a combination of two genomes, one a normal *M. edulis* genome and one a cancer from *M. trossulus*. This by itself is clearly not conclusive, and it led to the current study of those samples and others. We have attempted to expand and clarify our explanation of this in the text.

> 2\) What is meant by: We sequenced...and found more than the normal two alleles in \"most\" of them...What is \"most\"? There are many such examples.

In every case of ambiguous words, such as "many" or "most," we have replaced them with specific numbers. In the case specifically mentioned, "most" of four samples was three samples.

> 3\) The qPCR results from attempted cloning of disease alleles is confusing. Finding that two of four disease M. chilensis animals have high levels of the cancer associated allele while the other two did not -- are the authors suggesting yet another transmissible cancer lineage?

That is a likely possibility. Based on the complete absence of *Mytilus* BTN2 alleles at all four loci in those two *M. chilensis* samples, we conclude that those two samples do not have *Mytilus* BTN2. They therefore either 1) were misdiagnosed, 2) have conventional cancers that are not transmissible, or 3) have yet another transmissible cancer lineage that has not yet been described. We have clarified this in the text.

> 4\) Given the inability to consistently amplify cancer alleles in various samples, it is unclear how any conclusions regarding the contribution of the Canadian samples and M. trossulus can be made.

We are unable to consistently clone alleles from some cancer samples, but we are able to consistently amplify cancer-associated alleles by qPCR from all samples diagnosed as cancerous from *M. edulis* and *M. chilensis*, with the exception of the two *M. chilensis* samples that are negative at all four loci (and which therefore do not have *Mytilus* BTN2). We included analysis of the Canadian *M. trossulus* samples to determine if the *Mytilus* BTN2 alleles could be detectible in the normal population or in the samples positive for *Mytilus* BTN1. We did not find any *M. trossulus* samples with alleles that match *Mytilus* BTN2 at all loci (indeed no Canadian *M. trossulus* sample amplified at all with the *EF1alpha* cancer-specific primers). This showed that these diagnostic primers consistently identify *Mytilus* BTN2, and that *Mytilus* BTN2 was not found in that *M. trossulus* population and is distinct from *Mytilus* BTN1.

> 5\) It is also unclear how to interpret the fact that H4 cancer associated alleles are found in several normal M. trossulus animals. How many is \"some?\"

We have clarified ambiguous words in the text, like "some." Specifically, since all transmissible cancers arose from a single normal individual that had the first cancer that gave rise to the lineage, it is expected that alleles nearly matching the cancer could be found in normal animals in the population. Therefore, it is expected that some normal *M. trossulus* animals would have *H4* alleles nearly identical to *Mytilus* BTN1 and some other would have alleles nearly identical to *Mytilus* BTN2. Notably, no normal animal has yet been found with *Mytilus* BTN2 or BTN1-like alleles at all loci. The two individuals in which these cancer lineages first arose would, but those two individuals are long dead. We have elaborated on this in the text.

> 6\) Sequencing less than 1kb over 3 loci makes drawing conclusions about origin and hybridization tricky. As example, how did they determine that the EF1a \'cancer\' alleles were not copy number variants in the host? Were noncancerous tissues tested for absence of these alleles in carrier individuals? Specifically, looking only at normal alleles, there is a clear grouping based on species of origin in a phylogenetic tree There are three exceptions to this clustering, from one normal M. trossulus (MW59) and two diseased M. chilensis (Mch41 and Castro26) with some distinctly M. edulis-like alleles. These may reflect introgression or true hybrid individuals-MW59 also has an EF1α allele corresponding to M. edulis and likely represents a hybrid with this species, which has been introduced into Canada (Crego-Prieto et al., 2015).\" This sort of noise, although expected, becomes problematic when it encompasses a third of the data. Please explain in more detail your rationale for your conclusions and include a discussion of caveats.

As noted above, the gene trees shown in this study would be insufficient to resolve the coalescence and complete evolutionary history of the three sexual *Mytilus* species tested here.

We do have evidence of both introgression (at the *EF1alpha* locus) as well as hybrid individuals (such as MW59, noted above). However, the data on the cancer-associated alleles strongly support clonal, asexual lineages, and all four trees are completely concordant (with the exception of the finding of mitochondrial recombination in two individuals).
